CURR Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 aug 2023 @ 21:04):

Stats
Dagens volum	1 250.00
Gjennomsnittsvolum	17 656.00
Markedsverdi	8.21M
EPS	$-0.0308 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.523
ATR14	$0.0330 (30.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-09-23	Salkind Gene Z	Buy	117 647	Common Stock
2021-09-23	Salkind Gene Z	Buy	117 647	Restricted Stock Unit
2023-08-17	Salkind Gene Z	Buy	186 364	Restricted Stock Unit
2023-08-17	Bagg Gerald	Buy	186 364	Restricted Stock Unit
2023-08-17	Costantino Robert J	Buy	186 364	Restricted Stock Unit

INSIDER POWER
100.00
Last 90 transactions
Buy: 9 233 498 \| Sell: 208 150

Volum Korrelasjon

Lang: 0.25 (neutral)

Kort: -0.43 (neutral)

Signal:(51.795) Neutral

CURE Pharmaceutical Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

CURE Pharmaceutical Korrelasjon - Valuta/Råvare

-0.34
( neutral )

-0.59
( weak negative )

0.00
( neutral )

-0.17
( neutral )

-0.11
( neutral )

0.50
( weak )

CURE Pharmaceutical Økonomi

Annual	2022
Omsetning:	$4.90M
Bruttogevinst:	$3.34M (68.20 %)
EPS:	$-0.0912

FY	2022
Omsetning:	$4.90M
Bruttogevinst:	$3.34M (68.20 %)
EPS:	$-0.0912

FY	2021
Omsetning:	$6.56M
Bruttogevinst:	$4.38M (66.85 %)
EPS:	$-0.260

FY	2020
Omsetning:	$2.05M
Bruttogevinst:	$975 000 (47.54 %)
EPS:	$-0.650

Financial Reports:

No articles found.

CURE Pharmaceutical

CURE Pharmaceutical Holding Corp., a biopharmaceutical company, focuses on the development and manufacturing of drug formulation and drug delivery technologies to enhance drug safety, efficacy, and patient adherence. It operates through two segments, Cure and Sera Labs. The company's pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CUREfilm Canna, a cannabinoid product with optimized pharmacokinetic profiles using microCURE and CUREfilm technology; CUREfilm Anti-Viral, an orally bio-available anti-viral of an existing therapeutic leveraging existing pre-clinical/clinical safety and toxicity data; and CUREfilm Central Nervous System, a novel dosage form to treat mental health disorders, such as depression, PTSD, addiction disorders, obsessive compulsive disorders, and anxiety. It also sells various wellness products under its distribution partners' brands. In addition, the company develops 50,000IU and Vitamin D3 OTF for oral administration. It has a licensing agreement with Canopy Growth Corporation. The company was founded in 2011 and is headquartered in Oxnard, California.